US Stock MarketDetailed Quotes
IKT Inhibikase Therapeutics
- 2.0500
- -0.3100-13.14%
Close Nov 15 16:00 ET
- 2.0700
- +0.0200+0.98%
Post 19:14 ET
137.74MMarket Cap-657P/E (TTM)
2.3500High1.9400Low400.09KVolume2.3500Open2.3600Pre Close816.98KTurnover2.61%Turnover RatioLossP/E (Static)67.19MShares3.820052wk High-256.25P/B31.46MFloat Cap0.798152wk Low--Dividend TTM15.35MShs Float70.8000Historical High--Div YieldTTM17.37%Amplitude0.7900Historical Low2.0420Avg Price1Lot Size
Inhibikase Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -62.07%7.94M | -62.09%9.75M | -42.51%13.25M | -42.51%13.25M | -36.57%16.83M | -35.01%20.94M | -29.75%25.72M | -43.44%23.05M | -43.44%23.05M | -40.83%26.53M |
| -Cash and cash equivalents | 62.01%3.09M | -40.52%2.35M | 27.50%9.17M | 27.50%9.17M | 157.03%14.86M | -94.09%1.91M | -89.19%3.96M | -82.36%7.19M | -82.36%7.19M | -87.11%5.78M |
| -Short-term investments | -74.50%4.85M | -66.01%7.4M | -74.23%4.09M | -74.23%4.09M | -90.51%1.97M | --19.03M | --21.76M | --15.86M | --15.86M | --20.75M |
| Receivables | ---- | --0 | --0 | --0 | --0 | 1,114.96%79.6K | 34.49%64.52K | -63.79%39.88K | -63.79%39.88K | -93.64%13.84K |
| -Accounts receivable | ---- | --0 | --0 | --0 | --0 | 1,114.96%79.6K | 34.49%64.52K | -63.79%39.88K | -63.79%39.88K | --13.84K |
| Prepaid assets | -27.97%306.3K | -77.53%207.42K | -80.33%219.82K | -80.33%219.82K | -62.72%347.57K | -53.73%425.23K | 63.30%923.13K | 944.50%1.12M | 944.50%1.12M | 252.68%932.42K |
| Other current assets | -34.46%356.49K | -7.77%851.06K | 352.23%739.18K | 352.23%739.18K | -26.56%371.54K | -32.97%543.92K | -20.80%922.76K | -89.12%163.45K | -89.12%163.45K | -6.55%505.92K |
| Total current assets | -60.87%8.6M | -60.88%10.81M | -41.69%14.21M | -41.69%14.21M | -37.29%17.55M | -35.25%21.98M | -28.03%27.63M | -42.62%24.37M | -42.62%24.37M | -38.99%27.99M |
| Non current assets | ||||||||||
| Net PPE | -38.40%224K | -51.33%260.26K | -47.70%295.6K | -47.70%295.6K | -44.52%330.03K | 743.87%363.62K | --534.75K | --565.18K | --565.18K | --594.82K |
| -Gross PPE | -49.94%267.59K | -45.60%297.29K | -42.99%326.05K | -42.99%326.05K | -40.67%353.92K | 1,140.65%534.59K | --546.52K | --571.9K | --571.9K | --596.51K |
| -Accumulated depreciation | 74.50%-43.59K | -214.64%-37.02K | -352.97%-30.45K | -352.97%-30.45K | -1,320.88%-23.89K | ---170.97K | ---11.77K | ---6.72K | ---6.72K | ---1.68K |
| Total non current assets | -38.40%224K | -51.33%260.26K | -47.70%295.6K | -47.70%295.6K | -44.52%330.03K | 743.87%363.62K | --534.75K | --565.18K | --565.18K | --594.82K |
| Total assets | -60.50%8.83M | -60.70%11.07M | -41.83%14.51M | -41.83%14.51M | -37.44%17.88M | -34.26%22.35M | -26.64%28.16M | -41.28%24.94M | -41.28%24.94M | -37.69%28.58M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 101.26%1.52M | 64.15%1.57M | -10.65%1.03M | -10.65%1.03M | -5.97%734.56K | -12.35%754.15K | 18.96%959.08K | 5.63%1.15M | 5.63%1.15M | 41.07%781.22K |
| -accounts payable | 77.76%1.34M | 34.90%1.29M | -43.82%646.77K | -43.82%646.77K | -5.97%734.56K | -12.35%754.15K | 18.96%959.08K | 5.63%1.15M | 5.63%1.15M | 41.07%781.22K |
| -Other payable | --177.26K | --280.61K | --381.78K | --381.78K | ---- | ---- | ---- | ---- | ---- | ---- |
| Current accrued expenses | 13.30%1.55M | 71.24%2.18M | -16.20%1.62M | -16.20%1.62M | -34.37%1.21M | -58.55%1.37M | -62.22%1.27M | -15.50%1.94M | -15.50%1.94M | -2.97%1.85M |
| Current debt and capital lease obligation | 2.88%152.22K | 2.90%151.16K | 2.92%150.1K | 2.92%150.1K | 4.92%149.03K | --147.97K | --146.9K | -41.41%145.84K | -41.41%145.84K | -42.93%142.05K |
| -Current capital lease obligation | 2.88%152.22K | 2.90%151.16K | 2.92%150.1K | 2.92%150.1K | 4.92%149.03K | --147.97K | --146.9K | --145.84K | --145.84K | --142.05K |
| Current deferred liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --23.68K |
| Current liabilities | 35.55%3.7M | 58.89%4.23M | -6.95%3.44M | -6.95%3.44M | -14.67%2.74M | -39.13%2.73M | -39.18%2.66M | -8.85%3.7M | -8.85%3.7M | 18.66%3.21M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -82.93%25.61K | -67.25%58.33K | -56.13%90.12K | -56.13%90.12K | -47.84%121.01K | --149.97K | --178.11K | --205.45K | --205.45K | --232.02K |
| -Long term capital lease obligation | -82.93%25.61K | -67.25%58.33K | -56.13%90.12K | -56.13%90.12K | -47.84%121.01K | --149.97K | --178.11K | --205.45K | --205.45K | --232.02K |
| Total non current liabilities | -82.93%25.61K | -67.25%58.33K | -56.13%90.12K | -56.13%90.12K | -47.84%121.01K | --149.97K | --178.11K | --205.45K | --205.45K | --232.02K |
| Total liabilities | 29.38%3.73M | 50.98%4.29M | -9.54%3.53M | -9.54%3.53M | -16.90%2.86M | -35.79%2.88M | -35.11%2.84M | -3.79%3.9M | -3.79%3.9M | 27.23%3.45M |
| Shareholders'equity | ||||||||||
| Share capital | 36.38%7.22K | -79.14%6.48K | 46.45%6.19K | 46.45%6.19K | -78.75%5.36K | -79.03%5.29K | 23.11%31.06K | -83.21%4.22K | -83.21%4.22K | 0.29%25.23K |
| -common stock | 36.38%7.22K | -79.14%6.48K | 46.45%6.19K | 46.45%6.19K | -78.75%5.36K | -79.03%5.29K | 23.11%31.06K | -83.21%4.22K | -83.21%4.22K | 0.29%25.23K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -31.62%-76.51M | -36.68%-71.55M | -39.75%-66.9M | -39.75%-66.9M | -43.88%-62.72M | -48.67%-58.13M | -51.92%-52.35M | -60.55%-47.87M | -60.55%-47.87M | -75.95%-43.59M |
| Paid-in capital | 5.17%81.6M | 1.10%78.32M | 13.19%77.87M | 13.19%77.87M | 13.19%77.74M | 13.14%77.59M | 13.20%77.47M | 0.87%68.8M | 0.87%68.8M | 1.13%68.68M |
| Gains losses not affecting retained earnings | 40.26%-1.02K | -101.09%-1.8K | -99.16%877 | -99.16%877 | -100.53%-143 | ---1.71K | --165.82K | --104.72K | --104.72K | --26.83K |
| Total stockholders'equity | -73.82%5.1M | -73.24%6.78M | -47.81%10.98M | -47.81%10.98M | -40.25%15.02M | -34.02%19.46M | -25.55%25.32M | -45.24%21.04M | -45.24%21.04M | -41.76%25.14M |
| Total equity | -73.82%5.1M | -73.24%6.78M | -47.81%10.98M | -47.81%10.98M | -40.25%15.02M | -34.02%19.46M | -25.55%25.32M | -45.24%21.04M | -45.24%21.04M | -41.76%25.14M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data